Phibro Animal Health Corp當前公司基本面數據相對穩定,最新ESG揭露屬於行業中等水平。增長潛力很大。當前估值合理,在藥品行業排名30/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為43.00。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Phibro Animal Health Corp評分
相關信息
行業排名
30 / 159
全市場排名
103 / 4555
所屬行業
藥品
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看跌
Phibro Animal Health Corp亮點
亮點風險
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
公司代碼PAHC
公司Phibro Animal Health Corp
CEOBendheim (Jack C)
網址https://www.pahc.com/
常見問題
Phibro Animal Health Corp(PAHC)的當前股價是多少?
Phibro Animal Health Corp(PAHC)的當前股價是 40.060。
Phibro Animal Health Corp 的股票代碼是什麼?
Phibro Animal Health Corp的股票代碼是PAHC。
Phibro Animal Health Corp股票的52週最高點是多少?
Phibro Animal Health Corp股票的52週最高點是46.420。
Phibro Animal Health Corp股票的52週最低點是多少?
Phibro Animal Health Corp股票的52週最低點是16.160。
Phibro Animal Health Corp的市值是多少?
Phibro Animal Health Corp的市值是1.62B。
Phibro Animal Health Corp的淨利潤是多少?
Phibro Animal Health Corp的淨利潤為48.26M。
現在Phibro Animal Health Corp(PAHC)的股票是買入、持有還是賣出?
根據分析師評級,Phibro Animal Health Corp(PAHC)的總體評級為持有,目標價格為43.000。
Phibro Animal Health Corp(PAHC)股票的每股收益(EPS TTM)是多少
Phibro Animal Health Corp(PAHC)股票的每股收益(EPS TTM)是1.673。